Home/Tag: DeepPath-LYDIA

DeepPath™-LYDIA in Sectra Digital Pathology Solution

By |2022-12-21T10:21:14+02:00December 20th, 2022|Categories: News|Tags: , |

We are happy to announce that we completed our integration of DeepPathTM-LYDIA in the Sectra Digital Pathology solution. We are particularly excited as DeepPathTM-LYDIA is the first lymph-node metastasis detection solution to be officially featured in Sectra Amplifier Marketplace for Digital Pathology. About DeepPathTM-LYDIA DeepPathTM-LYDIA is DeepMed’s CE-Marked AI-powered decision support system for metastasis detection on [...]

CE Mark for DeepPath™ – LYDIA

By |2022-06-06T15:06:14+03:00June 6th, 2022|Categories: Uncategorized|Tags: , |

We are super excited to announce that DeepMedIO receives CE marking for DeepPath™ - LYDIA. The system got regulatory clearance as decision support as per IVDD for helping histopathologists detect metastases on Hematoxylin & Eosin stained lymph nodes from patients with breast cancer, colon cancer, lung cancer, and melanoma. We must note that to the best [...]

Go to Top